文献速递肿瘤 PET/CT

基于18F-氟脱氧葡萄糖正电子发射断层显像的影像组学与胰腺导管腺癌基因改变的影像表型研究

Imaging phenotype using 18F-fluorodeoxyglucose positron emission tomography-based radiomics and genetic alterations of pancreatic ductal adenocarcinoma.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2020-01-31

回顾性分析48例胰腺导管腺癌患者的治疗前FDG PET/CT影像组学特征与肿瘤组织基因组分析结果,发现KRAS突变与低强度纹理特征显著相关,SMAD4突变与标准化摄取值偏度及高强度纹理特征显著相关,TP53和CDKN2A突变与影像表型无显著关联。

要点

  • KRAS突变频率87.5%,与长游程强调、区域强调、大区域强调等低强度纹理特征显著相关。
  • SMAD4突变频率25.0%,与标准化摄取值偏度及游程强调、短游程强调、区域强调、短区域强调等高强度纹理特征显著相关。
  • TP53和CDKN2A突变与影像表型无显著关联。

核心结论

  • KRAS和SMAD4基因改变与胰腺导管腺癌的FDG PET影像组学特征存在显著关联。
  • PET影像组学可能以无创方式帮助临床医生预测基因改变状态。

研究设计与样本

  • 回顾性分析48例胰腺导管腺癌患者的治疗前FDG PET/CT影像及肿瘤组织基因组分析数据。

主要发现

  • 突变频率为KRAS 87.5%、TP53 70.8%、SMAD4 25.0%、CDKN2A 18.8%。
  • KRAS突变与低强度纹理特征显著相关,包括长游程强调(AUC=0.806)、区域强调(AUC=0.794)和大区域强调(AUC=0.829)。
  • SMAD4突变与标准化摄取值偏度(AUC=0.727)、长游程强调(AUC=0.692)及高强度纹理特征显著相关,包括游程强调(AUC=0.775)、短游程强调(AUC=0.736)、区域强调(AUC=0.750)和短区域强调(AUC=0.725)。
  • TP53和CDKN2A基因改变与影像表型之间未见显著关联。

关键数值与推荐

  • 从PET图像提取35个独特的定量影像组学特征,包括像素强度、形状和纹理特征等影像表型。
  • 采用定制癌症面板进行靶向外显子组测序用于基因组分析。
  • 使用受试者工作特征曲线下面积(AUC)评估基于PET影像组学的基因改变预测性能。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aimed to determine if major gene mutations including in KRAS, SMAD4, TP53, and CDKN2A were related to imaging phenotype using 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)-based radiomics in patients with pancreatic ductal adenocarcinoma (PDAC). METHODS: Data on 48 PDAC patients with pretreatment FDG PET/CT who underwent genomic analysis of their tumor tissue were retrospectively analyzed. A total of 35 unique quantitative radiomic features were extracted from PET images, including imaging phenotypes such as pixel intensity, shape, and textural features. Targeted exome sequencing using a customized cancer panel was used for genomic analysis. To assess the predictive performance of genetic alteration using PET-based radiomics, areas under the receiver operating characteristic curve (AUC) were used. RESULTS: Mutation frequencies were KRAS 87.5%, TP53 70.8%, SMAD4 25.0%, and CDKN2A 18.8%. KRAS gene mutations were significantly associated with low-intensity textural features, including long-run emphasis (AUC = 0.806), zone emphasis (AUC = 0.794), and large-zone emphasis (AUC = 0.829). SMAD4 gene mutations showed significant relationships with standardized uptake value skewness (AUC = 0.727), long-run emphasis (AUC = 0.692), and high-intensity textural features such as run emphasis (AUC = 0.775), short-run emphasis (AUC = 0.736), zone emphasis (AUC = 0.750), and short-zone emphasis (AUC = 0.725). No significant associations were seen between the imaging phenotypes and genetic alterations in TP53 and CDKN2A. CONCLUSION: Genetic alterations of KRAS and SMAD4 had significant associations with FDG PET-based radiomic features in PDAC. PET-based radiomics may help clinicians predict genetic alteration status in a noninvasive way.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Lim CH, Cho YS, Choi JY, et al. Imaging phenotype using 18F-fluorodeoxyglucose positron emission tomography-based radiomics and genetic alterations of pancreatic ductal adenocarcinoma. Eur J Nucl Med Mol Imaging. 2020. PMID: 32002592. doi:10.1007/s00259-020-04698-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。